title: Toxic epidermal necrolysis in a patient with cystic fibrosis.
authors.affiliation: Department of Medicine, Pulmonary Division and Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. Electronic address: f.tremblay@umontreal.ca.
authors.forename: François
authors.initials: F
authors.lastname: Tremblay
authors.affiliation: Department of Allergy and Clinical Immunology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
authors.forename: Hugo
authors.initials: H
authors.lastname: Chapdelaine
authors.affiliation: Department of Medicine, Pulmonary Division and Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
authors.forename: Annick
authors.initials: A
authors.lastname: Lavoie
authors.affiliation: Department of Medicine, Pulmonary Division and Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut de recherches cliniques de Montréal, Montréal, Québec, Canada.
authors.forename: Yves
authors.initials: Y
authors.lastname: Berthiaume
authors.affiliation: Department of Dermatology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
authors.forename: Laura
authors.initials: L
authors.lastname: Sabbah
authors.affiliation: Department of Dermatology, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
authors.forename: Steven C
authors.initials: SC
authors.lastname: Bernstein
authors.affiliation: Department of Medicine, Pulmonary Division and Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
authors.forename: Maïté
authors.initials: M
authors.lastname: Silviet-Carricart
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects; D003550:Cystic Fibrosis / Q000150:complications*; D006801:Humans; D008297:Male; D000077731:Meropenem; D010346:Patient Care Management / Q000379:methods; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D013845:Thienamycins / Q000008:administration & dosage / Q000009:adverse effects*; D014031:Tobramycin / Q000008:administration & dosage / Q000009:adverse effects*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D014640:Vancomycin; D000077731:Meropenem; D014031:Tobramycin